CIK 0001816736
- Large accelerated filer
Disc Medicine, Inc.
Sign in to watch- Ticker
- IRON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 851612845
- Phone
- +1 617-674-9274
- Business address
- 321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
- Former names
- Gemini Therapeutics, Inc. /DE, FS Development Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,877,065
- in 6 filings, $10.0M under 10b5-1 plans
Net −$11,877,065. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-23 | Redmond Precillia Chief People Officer | Grant or award · Stock Option (Right to Buy) | +25,489 | 25,489 | ||
| 2021-02-23 | Lauder Scott Chief Technology Officer | Grant or award · Stock Option (Right to Buy) | +272,615 | 272,615 | ||
| 2021-02-05 | Ong Tuyen Director | Grant or award · Stock Option (Right to Buy) | +58,855 | 58,855 | ||
| 2021-02-05 | Lubner David Charles Director | Grant or award · Stock Option (Right to Buy) | +58,855 | 58,855 | ||
| 2021-02-05 | Uknis Marc Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +277,117 | 277,117 | ||
| 2021-02-05 | Strapps Walter Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +79,094 | 79,094 | ||
| 2021-02-05 | Redmond Precillia Chief People Officer | Grant or award · Stock Option (Right to Buy) | +77,450 | 77,450 | ||
| 2021-02-05 | Meyenburg Jason Patrick President & CEO | Grant or award · Stock Option (Right to Buy) | +1,124,832 | 1,124,832 | ||
| 2021-02-05 | Lauder Scott Chief Technology Officer | Grant or award · Stock Option (Right to Buy) | +243,996 | 243,996 | ||
| 2021-02-05 | Tananbaum James B. Director | Grant or award | +1,500,000 | $10.00 | $15.0M | 1,500,000 |
| 2021-02-05 | Tananbaum James B. Director | Conversion | +2,928,750 | 2,928,750 | ||
| 2021-02-05 | Tananbaum James B. Director | Conversion · Common Stock | −2,928,750 | 0 | ||
| 2021-02-05 | FS Development Holdings, LLC 10% owner | Grant or award | +1,500,000 | $10.00 | $15.0M | 1,500,000 |
| 2021-02-05 | FS Development Holdings, LLC 10% owner | Conversion | +2,928,750 | 2,928,750 | ||
| 2021-02-05 | FS Development Holdings, LLC 10% owner | Conversion · Common Stock | −2,928,750 | 0 | ||
| 2020-08-14 | FS Development Holdings, LLC 10% owner | Purchase | +441,500 | $10.00 | $4.4M | 441,500 |
Page 34 of 34 · 676 trades